Literature DB >> 26305047

Development, Homeostasis, and Heterogeneity of NK Cells and ILC1.

Cyril Seillet1,2, Gabrielle T Belz3,4, Nicholas D Huntington5,6.   

Abstract

Natural killer (NK) cells are a population of cytotoxic innate lymphocytes that evolved prior to their adaptive counterparts and constitute one of the first lines of defense against infected or mutated cells. NK cells are rapidly activated, expressing an array of germ-line encoded receptors that allow them to scan for protein irregularities on cells and kill those deemed "altered-self." NK cells rapidly produce a broad range of cytokines and chemokines following activation by virus, bacterial, or parasitic infection and are thus key in orchestrating inflammation. NK cells have previously been viewed to represent a relatively homogeneous group of IFN-γ-producing cells that express the surface markers NK1.1 and natural killer cell p46-related protein (NKp46 or NCR1 encoded by Ncr1) and depend on the transcription factor T-bet for their development. Recently, a second subset of T-bet-dependent innate cells, the group 1 innate lymphoid cells (ILC1), has been discovered which share many attributes of conventional NK (cNK) cells. Despite the similarities between ILC1 and cNK cells , they differ in several important aspects including their localization, transcriptional regulation, and phenotype suggesting each subset has distinct origins and functions in immune responses. Previously, the ability to detect and spontaneously kill cells that exhibit "altered-self" which is central to tumor and viral immunity has been thought to be an attribute restricted solely to cNK cells. The identification of ILC1 challenges this notion and suggests that key contributions from ILC1 may have gone unrecognized. Thus, understanding the different rules that govern the behavior of ILC1 and cNK cells in immune responses may potentially open unexpected doorways to uncover novel strategies to manipulate these cells in treating disease. Here, we review recent advances in our understanding of peripheral cNK cell and ILC1 heterogeneity in terms of their development, phenotype, homeostasis, and effector functions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26305047     DOI: 10.1007/82_2015_474

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  28 in total

1.  Association of peripheral NK cell counts with Helios+ IFN-γ- Tregs in patients with good long-term renal allograft function.

Authors:  K Trojan; L Zhu; M Aly; R Weimer; N Bulut; C Morath; G Opelz; V Daniel
Journal:  Clin Exp Immunol       Date:  2017-03-13       Impact factor: 4.330

Review 2.  Development of innate lymphoid cells.

Authors:  Erin C Zook; Barbara L Kee
Journal:  Nat Immunol       Date:  2016-06-21       Impact factor: 25.606

3.  Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes.

Authors:  Tsukasa Nabekura; Luke Riggan; Andrew D Hildreth; Timothy E O'Sullivan; Akira Shibuya
Journal:  Immunity       Date:  2019-12-03       Impact factor: 31.745

Review 4.  The Tumor Microenvironment Innately Modulates Cancer Progression.

Authors:  Dominique C Hinshaw; Lalita A Shevde
Journal:  Cancer Res       Date:  2019-07-26       Impact factor: 12.701

5.  Cutting Edge: Inhibition of the Interaction of NK Inhibitory Receptors with MHC Class I Augments Antiviral and Antitumor Immunity.

Authors:  Abir K Panda; Arunakumar Gangaplara; Maja Buszko; Kannan Natarajan; Lisa F Boyd; Suveena Sharma; David H Margulies; Ethan M Shevach
Journal:  J Immunol       Date:  2020-06-29       Impact factor: 5.422

Review 6.  Roles of cytotoxic and helper innate lymphoid cells in cancer.

Authors:  Camille Guillerey
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

7.  Changes in Gene Expression and Metabolism in the Testes of the Rat following Spinal Cord Injury.

Authors:  Ryan D Fortune; Raymond J Grill; Christine Beeton; Mark Tanner; Redwan Huq; David S Loose
Journal:  J Neurotrauma       Date:  2016-12-02       Impact factor: 5.269

8.  Roles of Type 1, 2, and 3 Innate Lymphoid Cells in Herpes Simplex Virus 1 Infection In Vitro and In Vivo.

Authors:  Satoshi Hirose; Shaohui Wang; Kati Tormanen; Yizhou Wang; Jie Tang; Omid Akbari; Homayon Ghiasi
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

Review 9.  Antiviral Activities of Group I Innate Lymphoid Cells.

Authors:  Ramon A Lujan; Sophia M Vrba; Heather D Hickman
Journal:  J Mol Biol       Date:  2021-09-22       Impact factor: 5.469

Review 10.  Friend or foe of innate lymphoid cells in inflammation-associated cardiovascular disease.

Authors:  Xiangmei Gong; Lin Xia; Zhaoliang Su
Journal:  Immunology       Date:  2020-10-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.